Background Which medication, if any, to use to prevent the headache of pediatric migraine
has not been established. Methods We conducted a randomized, double-blind, placebo-…

Background There are limited treatments for progressive multiple sclerosis. Ibudilast inhibits
several cyclic nucleotide phosphodiesterases, macrophage migration inhibitory factor, and …

Importance There is a critical need for careful and independent validation of reported
symptomatic efficacy and dopaminergic biomarker changes induced by nilotinib in Parkinson …

BACKGROUND FXLEARN, the first-ever large multisite trial of effects of disease-targeted
pharmacotherapy on learning, was designed to explore a paradigm for measuring effects of …

Objective To determine whether ibudilast has an effect on brain volume and new lesions in
progressive forms of multiple sclerosis (MS). Methods A randomized, placebo-controlled, …

Objective To describe baseline headache characteristics of children and adolescents
participating in a multicenter, randomized, double‐blinded, placebo‐controlled, comparative …

Importance Migraine is a common neurological disease that often begins in childhood and
continues into adulthood; approximately 6 million children and adolescents in the United …

Background: The SPRINT-MS trial demonstrated benefit of ibudilast on brain atrophy over
96 weeks in progressive multiple sclerosis (MS). Optical coherence tomography (OCT) was …

Importance Cryptogenic sensory peripheral neuropathy (CSPN) is highly prevalent and
often disabling due to neuropathic pain. Metabolic syndrome and its components increase …

Objective To examine group differences in self‐reported migraine days among youth who
completed the Childhood and Adolescent Migraine Prevention (CHAMP) trial prior to its …